You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

DESOGESTREL AND ETHINYL ESTRADIOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Desogestrel And Ethinyl Estradiol, and when can generic versions of Desogestrel And Ethinyl Estradiol launch?

Desogestrel And Ethinyl Estradiol is a drug marketed by Duramed Pharms Barr, Dr Reddys Labs Sa, Naari Pte Ltd, Novast Labs, Watson Labs, and Xiromed. and is included in nine NDAs.

The generic ingredient in DESOGESTREL AND ETHINYL ESTRADIOL is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Desogestrel And Ethinyl Estradiol

A generic version of DESOGESTREL AND ETHINYL ESTRADIOL was approved as desogestrel; ethinyl estradiol by DURAMED PHARMS BARR on August 12th, 1999.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DESOGESTREL AND ETHINYL ESTRADIOL?
  • What are the global sales for DESOGESTREL AND ETHINYL ESTRADIOL?
  • What is Average Wholesale Price for DESOGESTREL AND ETHINYL ESTRADIOL?
Summary for DESOGESTREL AND ETHINYL ESTRADIOL
Drug patent expirations by year for DESOGESTREL AND ETHINYL ESTRADIOL
Recent Clinical Trials for DESOGESTREL AND ETHINYL ESTRADIOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Laboratorios Andromaco S.A.Phase 1
University of PennsylvaniaPhase 3
Milton S. Hershey Medical CenterPhase 3

See all DESOGESTREL AND ETHINYL ESTRADIOL clinical trials

US Patents and Regulatory Information for DESOGESTREL AND ETHINYL ESTRADIOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Duramed Pharms Barr DESOGESTREL AND ETHINYL ESTRADIOL desogestrel; ethinyl estradiol TABLET;ORAL-21 075256-001 Aug 12, 1999 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Novast Labs DESOGESTREL AND ETHINYL ESTRADIOL desogestrel; ethinyl estradiol TABLET;ORAL-28 091234-001 Jul 12, 2013 AB RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Duramed Pharms Barr DESOGESTREL AND ETHINYL ESTRADIOL desogestrel; ethinyl estradiol TABLET;ORAL-28 075256-002 Aug 12, 1999 AB RX No Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Watson Labs DESOGESTREL AND ETHINYL ESTRADIOL desogestrel; ethinyl estradiol TABLET;ORAL-28 076915-001 Jul 29, 2005 AB RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.